Intra Cellular Therapies | ITCI - Ebitda



Ebitda Changement Date
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
ALKERMES USD 100.31M 21.24M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Cytokinetics USD -277.18M 169.36M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
J&J USD 7.19B 2.32B 2025-12
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.84B 235M 2025-09
Prothena USD -39.53M 12.25M 2025-09
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12